Viatris Inc. (VTRS)
USD 7.63
(1.19%)
USD 7.63
(1.19%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 47.68 Billion USD | -4.67% |
| 2022 | 50.02 Billion USD | -8.79% |
| 2021 | 54.84 Billion USD | -10.9% |
| 2020 | 61.55 Billion USD | 96.93% |
| 2019 | 31.25 Billion USD | -4.52% |
| 2018 | 32.73 Billion USD | -8.58% |
| 2017 | 35.8 Billion USD | 3.11% |
| 2016 | 34.72 Billion USD | 55.95% |
| 2015 | 22.26 Billion USD | 40.75% |
| 2014 | 15.82 Billion USD | 3.44% |
| 2013 | 15.29 Billion USD | 28.18% |
| 2012 | 11.93 Billion USD | 2.88% |
| 2011 | 11.59 Billion USD | 0.53% |
| 2010 | 11.53 Billion USD | 6.81% |
| 2009 | 10.8 Billion USD | 3.93% |
| 2008 | 10.39 Billion USD | -8.45% |
| 2007 | 11.35 Billion USD | 0.0% |
| 2006 | 1.87 Billion USD | -12.42% |
| 2005 | 1.87 Billion USD | -12.42% |
| 2004 | 2.13 Billion USD | 13.88% |
| 2003 | 1.87 Billion USD | 0.0% |
| 2002 | 1.61 Billion USD | 10.28% |
| 2001 | 1.46 Billion USD | 9.3% |
| 2000 | 1.34 Billion USD | 11.15% |
| 1999 | 1.2 Billion USD | 42.33% |
| 1998 | 847.8 Million USD | 9.03% |
| 1997 | 777.6 Million USD | 12.37% |
| 1996 | 692 Million USD | 26.69% |
| 1995 | 546.2 Million USD | 35.43% |
| 1994 | 403.3 Million USD | 14.87% |
| 1993 | 351.1 Million USD | 54.87% |
| 1992 | 226.7 Million USD | 33.67% |
| 1991 | 169.6 Million USD | 23.35% |
| 1990 | 137.5 Million USD | 22.01% |
| 1989 | 112.7 Million USD | 3.58% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 45.33 Billion USD | -4.25% |
| 2024 Q1 | 47.34 Billion USD | -0.72% |
| 2023 FY | 47.68 Billion USD | -4.67% |
| 2023 Q4 | 47.68 Billion USD | -2.17% |
| 2023 Q3 | 48.74 Billion USD | 0.1% |
| 2023 Q1 | 49.29 Billion USD | -1.46% |
| 2023 Q2 | 48.69 Billion USD | -1.21% |
| 2022 Q4 | 50.02 Billion USD | 2.79% |
| 2022 FY | 50.02 Billion USD | -8.79% |
| 2022 Q1 | 53.46 Billion USD | -2.51% |
| 2022 Q2 | 51.12 Billion USD | -4.38% |
| 2022 Q3 | 48.66 Billion USD | -4.82% |
| 2021 Q2 | 57.98 Billion USD | -1.69% |
| 2021 Q3 | 56.07 Billion USD | -3.3% |
| 2021 Q4 | 54.84 Billion USD | -2.19% |
| 2021 FY | 54.84 Billion USD | -10.9% |
| 2021 Q1 | 58.97 Billion USD | -4.18% |
| 2020 Q1 | 30.14 Billion USD | -3.55% |
| 2020 Q2 | 30.15 Billion USD | 0.03% |
| 2020 Q3 | 31.24 Billion USD | 3.61% |
| 2020 Q4 | 61.55 Billion USD | 97.01% |
| 2020 FY | 61.55 Billion USD | 96.93% |
| 2019 Q3 | 31.05 Billion USD | -2.4% |
| 2019 Q4 | 31.25 Billion USD | 0.65% |
| 2019 Q1 | 31.9 Billion USD | -2.53% |
| 2019 FY | 31.25 Billion USD | -4.52% |
| 2019 Q2 | 31.81 Billion USD | -0.28% |
| 2018 Q2 | 33.27 Billion USD | -5.44% |
| 2018 FY | 32.73 Billion USD | -8.58% |
| 2018 Q4 | 32.73 Billion USD | -2.15% |
| 2018 Q3 | 33.45 Billion USD | 0.55% |
| 2018 Q1 | 35.18 Billion USD | -1.74% |
| 2017 Q3 | 35.81 Billion USD | 0.88% |
| 2017 FY | 35.8 Billion USD | 3.11% |
| 2017 Q4 | 35.8 Billion USD | -0.04% |
| 2017 Q2 | 35.5 Billion USD | 3.6% |
| 2017 Q1 | 34.27 Billion USD | -1.31% |
| 2016 Q4 | 34.72 Billion USD | -4.96% |
| 2016 Q2 | 28.83 Billion USD | 27.35% |
| 2016 Q3 | 36.53 Billion USD | 26.71% |
| 2016 FY | 34.72 Billion USD | 55.95% |
| 2016 Q1 | 22.64 Billion USD | 1.69% |
| 2015 Q3 | 21.31 Billion USD | -6.48% |
| 2015 Q1 | 22.12 Billion USD | 39.84% |
| 2015 Q2 | 22.79 Billion USD | 3.03% |
| 2015 Q4 | 22.26 Billion USD | 4.46% |
| 2015 FY | 22.26 Billion USD | 40.17% |
| 2014 Q2 | 15.6 Billion USD | 1.61% |
| 2014 Q4 | 15.82 Billion USD | 4.26% |
| 2014 Q1 | 15.35 Billion USD | 0.39% |
| 2014 Q3 | 15.17 Billion USD | -2.75% |
| 2014 FY | 15.88 Billion USD | 4.27% |
| 2013 FY | 15.23 Billion USD | 27.69% |
| 2013 Q1 | 11.88 Billion USD | -0.39% |
| 2013 Q2 | 12.21 Billion USD | 2.75% |
| 2013 Q4 | 15.29 Billion USD | 18.55% |
| 2013 Q3 | 12.9 Billion USD | 0.0% |
| 2012 FY | 11.93 Billion USD | 2.88% |
| 2012 Q2 | 11.6 Billion USD | -2.78% |
| 2012 Q1 | 11.93 Billion USD | 2.9% |
| 2012 Q3 | 11.7 Billion USD | 0.9% |
| 2012 Q4 | 11.93 Billion USD | 1.93% |
| 2011 Q3 | 11.11 Billion USD | -7.39% |
| 2011 Q1 | 11.87 Billion USD | 2.96% |
| 2011 FY | 11.59 Billion USD | 0.53% |
| 2011 Q4 | 11.59 Billion USD | 4.32% |
| 2011 Q2 | 12 Billion USD | 1.07% |
| 2010 Q4 | 11.53 Billion USD | 1.14% |
| 2010 FY | 11.53 Billion USD | 6.81% |
| 2010 Q3 | 11.4 Billion USD | 7.64% |
| 2010 Q2 | 10.59 Billion USD | -2.08% |
| 2010 Q1 | 10.82 Billion USD | 0.19% |
| 2009 Q2 | 10.24 Billion USD | 3.5% |
| 2009 Q1 | 9.89 Billion USD | -4.93% |
| 2009 FY | 10.8 Billion USD | 3.76% |
| 2009 Q4 | 10.8 Billion USD | 0.36% |
| 2009 Q3 | 10.76 Billion USD | 5.08% |
| 2008 Q4 | 10.4 Billion USD | -5.57% |
| 2008 Q2 | 11.5 Billion USD | -0.83% |
| 2008 Q1 | 11.59 Billion USD | 0.0% |
| 2008 FY | 10.4 Billion USD | -8.31% |
| 2008 Q3 | 11.02 Billion USD | -4.16% |
| 2007 Q2 | 4.47 Billion USD | 5.21% |
| 2007 FY | 11.35 Billion USD | 506.95% |
| 2007 Q1 | 4.25 Billion USD | 92.78% |
| 2007 Q3 | 4.47 Billion USD | 0.02% |
| 2006 Q1 | 1.87 Billion USD | 1.93% |
| 2006 Q2 | 1.98 Billion USD | 6.08% |
| 2006 Q3 | 2.03 Billion USD | 2.59% |
| 2006 Q4 | 2.2 Billion USD | 8.4% |
| 2006 FY | 1.87 Billion USD | -12.42% |
| 2005 Q1 | 2.13 Billion USD | 5.28% |
| 2005 FY | 2.13 Billion USD | 13.88% |
| 2005 Q2 | 2.18 Billion USD | 2.4% |
| 2005 Q3 | 1.91 Billion USD | -12.48% |
| 2005 Q4 | 1.83 Billion USD | -4.12% |
| 2004 Q1 | 1.87 Billion USD | -0.3% |
| 2004 Q4 | 2.02 Billion USD | 1.75% |
| 2004 Q3 | 1.99 Billion USD | -1.24% |
| 2004 FY | 1.87 Billion USD | 7.45% |
| 2004 Q2 | 2.01 Billion USD | 7.64% |
| 2003 Q4 | 1.88 Billion USD | 4.48% |
| 2003 Q2 | 1.69 Billion USD | -3.01% |
| 2003 Q1 | 1.74 Billion USD | -0.52% |
| 2003 FY | 1.74 Billion USD | 7.95% |
| 2003 Q3 | 1.8 Billion USD | 6.36% |
| 2002 Q4 | 1.75 Billion USD | 2.66% |
| 2002 Q3 | 1.7 Billion USD | 4.49% |
| 2002 Q2 | 1.63 Billion USD | 1.16% |
| 2002 FY | 1.61 Billion USD | 10.28% |
| 2002 Q1 | 1.61 Billion USD | -6.91% |
| 2001 Q2 | 1.53 Billion USD | 4.71% |
| 2001 FY | 1.46 Billion USD | 9.3% |
| 2001 Q4 | 1.73 Billion USD | 5.39% |
| 2001 Q3 | 1.64 Billion USD | 7.35% |
| 2001 Q1 | 1.46 Billion USD | 4.92% |
| 2000 Q1 | 1.34 Billion USD | 2.46% |
| 2000 Q3 | 1.33 Billion USD | -2.24% |
| 2000 FY | 1.34 Billion USD | 11.15% |
| 2000 Q4 | 1.39 Billion USD | 4.73% |
| 2000 Q2 | 1.36 Billion USD | 1.76% |
| 1999 Q1 | 1.2 Billion USD | 4.18% |
| 1999 Q2 | 1.24 Billion USD | 2.85% |
| 1999 Q3 | 1.25 Billion USD | 1.51% |
| 1999 FY | 1.2 Billion USD | 42.33% |
| 1999 Q4 | 1.3 Billion USD | 3.91% |
| 1998 Q2 | 890.9 Million USD | 5.08% |
| 1998 Q1 | 847.8 Million USD | 4.02% |
| 1998 Q3 | 924.4 Million USD | 3.76% |
| 1998 Q4 | 1.15 Billion USD | 25.3% |
| 1998 FY | 847.8 Million USD | 9.03% |
| 1997 Q3 | 815.8 Million USD | 3.59% |
| 1997 Q4 | 815 Million USD | -0.1% |
| 1997 Q1 | 777.6 Million USD | -0.37% |
| 1997 FY | 777.6 Million USD | 12.37% |
| 1997 Q2 | 787.5 Million USD | 1.27% |
| 1996 Q1 | 692 Million USD | 12.94% |
| 1996 Q4 | 780.5 Million USD | 2.04% |
| 1996 Q3 | 764.9 Million USD | 7.48% |
| 1996 Q2 | 711.7 Million USD | 2.85% |
| 1996 FY | 692 Million USD | 26.69% |
| 1995 FY | 546.2 Million USD | 35.43% |
| 1995 Q2 | 571.5 Million USD | 4.63% |
| 1995 Q1 | 546.2 Million USD | 7.48% |
| 1995 Q4 | 612.7 Million USD | 4.48% |
| 1995 Q3 | 586.4 Million USD | 2.61% |
| 1994 Q3 | 476 Million USD | 6.37% |
| 1994 Q1 | 403.3 Million USD | 2.46% |
| 1994 Q2 | 447.5 Million USD | 10.96% |
| 1994 Q4 | 508.2 Million USD | 6.76% |
| 1994 FY | 403.3 Million USD | 14.87% |
| 1993 Q1 | 351.1 Million USD | 22.12% |
| 1993 Q3 | 371.2 Million USD | 1.53% |
| 1993 FY | 351.1 Million USD | 54.87% |
| 1993 Q2 | 365.6 Million USD | 4.13% |
| 1993 Q4 | 393.6 Million USD | 6.03% |
| 1992 Q1 | 226.7 Million USD | 6.08% |
| 1992 Q3 | 258.4 Million USD | 7.89% |
| 1992 Q2 | 239.5 Million USD | 5.65% |
| 1992 Q4 | 287.5 Million USD | 11.26% |
| 1992 FY | 226.7 Million USD | 33.67% |
| 1991 Q4 | 213.7 Million USD | 14.4% |
| 1991 Q3 | 186.8 Million USD | 4.65% |
| 1991 FY | 169.6 Million USD | 23.35% |
| 1991 Q2 | 178.5 Million USD | 5.25% |
| 1991 Q1 | 169.6 Million USD | 4.05% |
| 1990 Q2 | 148.4 Million USD | 7.93% |
| 1990 Q3 | 156.9 Million USD | 5.73% |
| 1990 Q4 | 163 Million USD | 3.89% |
| 1990 FY | 137.5 Million USD | 22.01% |
| 1990 Q1 | 137.5 Million USD | 0.88% |
| 1989 Q1 | 112.7 Million USD | 0.0% |
| 1989 Q4 | 136.3 Million USD | 11.17% |
| 1989 Q3 | 122.6 Million USD | 2.85% |
| 1989 Q2 | 119.2 Million USD | 5.77% |
| 1989 FY | 112.7 Million USD | 3.58% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Collegium Pharmaceutical, Inc. | 1.14 Billion USD | -4070.836% |
| Embecta Corp. | 1.21 Billion USD | -3826.672% |
| ANI Pharmaceuticals, Inc. | 904.42 Million USD | -5172.483% |
| Dynavax Technologies Corporation | 997.09 Million USD | -4682.438% |
| Esperion Therapeutics, Inc. | 205.79 Million USD | -23071.247% |
| Pacira BioSciences, Inc. | 1.57 Billion USD | -2928.832% |
| PainReform Ltd. | 9.93 Million USD | -480116.516% |
| Aquestive Therapeutics, Inc. | 57.41 Million USD | -82949.74% |
| Sunshine Biopharma, Inc. | 27.34 Million USD | -174272.209% |
| SCYNEXIS, Inc. | 128.41 Million USD | -37034.769% |
| China SXT Pharmaceuticals, Inc. | 23.12 Million USD | -206089.227% |
| Cosmos Health Inc. | 66.29 Million USD | -71828.634% |
| Journey Medical Corporation | 76.84 Million USD | -61950.905% |
| Sunshine Biopharma, Inc. | 27.34 Million USD | -174272.209% |
| Safety Shot Inc | 12.7 Million USD | -375105.167% |
| Alpha Teknova, Inc. | 128.58 Million USD | -36984.231% |
| Intra-Cellular Therapies, Inc. | 728.29 Million USD | -6447.553% |
| Bright Green Corporation | 17.4 Million USD | -273906.615% |
| Procaps Group, S.A. | 460.18 Million USD | -10262.201% |
| Theratechnologies Inc. | 77.76 Million USD | -61216.849% |
| Harrow Health, Inc. | 311.75 Million USD | -15195.825% |
| Sonoma Pharmaceuticals, Inc. | 14.89 Million USD | -320087.336% |
| Biofrontera Inc. | 27.93 Million USD | -170619.963% |
| DURECT Corporation | 45.18 Million USD | -105424.575% |
| Supernus Pharmaceuticals, Inc. | 1.4 Billion USD | -3284.406% |
| Cronos Group Inc. | 1.13 Billion USD | -4104.136% |
| OptiNose, Inc. | 107.72 Million USD | -44164.311% |
| Ironwood Pharmaceuticals, Inc. | 471.07 Million USD | -10022.741% |
| Kala Pharmaceuticals, Inc. | 55.94 Million USD | -85130.299% |
| RedHill Biopharma Ltd. | 23.04 Million USD | -206804.233% |
| Organogenesis Holdings Inc. | 460.02 Million USD | -10265.85% |
| Guardion Health Sciences, Inc. | 11.91 Million USD | -400007.332% |
| Cumberland Pharmaceuticals Inc. | 81.77 Million USD | -58212.288% |
| Radius Health, Inc. | 1.71 Billion USD | -2678.958% |
| Universe Pharmaceuticals INC | 53.28 Million USD | -89388.002% |
| ProPhase Labs, Inc. | 91.92 Million USD | -51773.225% |
| Phibro Animal Health Corporation | 982.18 Million USD | -4755.048% |
| Procaps Group S.A. | 460.18 Million USD | -10262.201% |
| Alvotech | 950.09 Million USD | -4919.051% |
| TherapeuticsMD, Inc. | 43.3 Million USD | -110005.29% |
| Rockwell Medical, Inc. | 52.17 Million USD | -91298.808% |
| Aytu BioPharma, Inc. | 118.09 Million USD | -40278.932% |
| SIGA Technologies, Inc. | 254.83 Million USD | -18612.216% |
| Tilray Brands, Inc. | 4.33 Billion USD | -999.937% |
| Lifecore Biomedical, Inc. | 273.7 Million USD | -17322.416% |
| Shineco, Inc. | 84.17 Million USD | -56547.484% |
| PetIQ, Inc. | 868.22 Million USD | -5392.291% |
| Regencell Bioscience Holdings Limited | 8.43 Million USD | -565013.861% |
| Incannex Healthcare Limited | 17.04 Million USD | -279629.571% |
| Neurocrine Biosciences, Inc. | 3.25 Billion USD | -1366.614% |
| Alimera Sciences, Inc. | 153.52 Million USD | -30960.616% |
| Silver Spike Investment Corp. | 88.57 Million USD | -53735.524% |
| Assertio Holdings, Inc. | 286.41 Million USD | -16548.861% |
| Shuttle Pharmaceuticals Holdings, Inc. | 5.95 Million USD | -801103.212% |
| Petros Pharmaceuticals, Inc. | 33.79 Million USD | -140998.915% |
| Clever Leaves Holdings Inc. | 31.24 Million USD | -152527.789% |
| Cyclo Therapeutics, Inc. | 13.24 Million USD | -359857.45% |
| Avadel Pharmaceuticals plc | 261.12 Million USD | -18161.491% |
| Hempacco Co., Inc. | 18.04 Million USD | -264186.918% |
| Talphera, Inc. | 20.39 Million USD | -233709.757% |
| Alvotech | 950.09 Million USD | -4919.051% |
| Eagle Pharmaceuticals, Inc. | 406.16 Million USD | -11640.57% |
| Lantheus Holdings, Inc. | 1.65 Billion USD | -2788.019% |
| Currenc Group, Inc. | 141.49 Million USD | -33602.279% |
| Kamada Ltd. | 351.96 Million USD | -13448.182% |
| Indivior PLC | 1.95 Billion USD | -2343.855% |
| Evoke Pharma, Inc. | 7.06 Million USD | -674515.402% |
| Flora Growth Corp. | 23.62 Million USD | -201734.843% |
| Cyclo Therapeutics, Inc. | 13.24 Million USD | -359857.45% |
| Evolus, Inc. | 188.99 Million USD | -25130.69% |
| HUTCHMED (China) Limited | 1.27 Billion USD | -3626.09% |
| Amphastar Pharmaceuticals, Inc. | 1.51 Billion USD | -3051.902% |
| Akanda Corp. | 8.83 Million USD | -539329.16% |